Overview

Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

Status:
Withdrawn
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Opioids lessen pain caused by cancer. It is not yet known whether opioids are more effective when given together with or without olanzapine in treating cancer pain. PURPOSE: This randomized clinical trial is studying opioids to see how well they work when given together with or without olanzapine in treating patients with moderate to severe cancer pain.
Phase:
N/A
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Cancer Institute (NCI)
Treatments:
Olanzapine